Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,121
Total Claims
$2.4M
Drug Cost
775
Beneficiaries
$3,052
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 13,194 Neurology providers
+255%
Opioid rate vs peers
4.6% vs 1.3% avg
-24%
Cost per patient vs peers
$3,052 vs $4,034 avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid rate is 255% above Neurology peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
4.6%
Opioid Rate
423
Opioid Claims
$7,628
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 0 claims · $0
Generic: 8,224 claims · $466K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Immun Glob G(Igg)/Gly/Iga 0-50 | 26 | $313K |
| Teriflunomide | 30 | $305K |
| Erenumab-Aooe | 230 | $186K |
| Teriflunomide | 24 | $156K |
| Interferon Beta-1a/Albumin | 11 | $118K |
| Onabotulinumtoxina | 48 | $76K |
| Ubrogepant | 69 | $75K |
| Galcanezumab-Gnlm | 79 | $61K |
| Eslicarbazepine Acetate | 33 | $55K |
| Lamotrigine | 11 | $51K |
| Pregabalin | 427 | $29K |
| Atogepant | 23 | $29K |
| Dextromethorphan Hbr/Quinidine | 15 | $25K |
| Istradefylline | 11 | $24K |
| Lacosamide | 85 | $19K |
Prescribing Profile
Patient Profile
67
Avg Age
61%
Female
1.58
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About